Behavioral Problems at Age 11 Years After Prenatal and Postnatal Exposure to Acetaminophen: Parent-Reported and

Insights

Prenatal acetaminophen exposure is linked to increased behavioral problems in children up to age 11. This includes total difficulties, internalizing, and externalizing behaviors, with risks rising with longer exposure duration.

Area of Science:

  • Epidemiology
  • Developmental Psychology
  • Pharmacology

Background:

  • Acetaminophen (paracetamol) is a widely used analgesic and antipyretic during pregnancy.
  • Previous research suggests potential links between prenatal acetaminophen exposure and adverse behavioral outcomes in early childhood.
  • The long-term effects and associations with postnatal exposure require further investigation.

Purpose of the Study:

  • To investigate the associations between prenatal and postnatal acetaminophen exposure and behavioral problems in children at 11 years of age.
  • To utilize both parent and child-reported behavioral measures for a comprehensive assessment.
  • To examine the dose-response relationship between cumulative exposure duration and behavioral outcomes.

Main Methods:

  • Utilized data from 40,934 mother-child pairs in the Danish National Birth Cohort (1996-2002).
  • Collected Strengths and Difficulties Questionnaire (SDQ) data from parents and children at 11-year follow-up.
  • Estimated risk ratios for behavioral problems (total difficulties, internalizing, externalizing) associated with prenatal and postnatal acetaminophen exposure.

Main Results:

  • Prenatal acetaminophen exposure showed a 10%-40% increased risk for total difficulties, internalizing, and externalizing problems, with stronger associations for longer exposure.
  • Postnatal exposure was linked to a 16%-19% higher risk of parent-reported internalizing behaviors, but associations were weak for child-reported measures.
  • Moderate correlations were observed between parent- and child-reported SDQ scores, particularly for externalizing behaviors (r=0.59).

Conclusions:

  • Findings corroborate existing evidence on prenatal acetaminophen exposure and behavioral issues, extending observations to early adolescence.
  • The study highlights the potential impact of prenatal exposure on child behavior development.
  • Further research is warranted to understand the mechanisms and clinical implications of these associations.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
575
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
93
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
121
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
319
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
381